Old Web
English
Sign In
Acemap
>
authorDetail
>
Rasmus S. Ripa
Rasmus S. Ripa
Medicine
Type 2 diabetes
Liraglutide
Internal medicine
secondary analysis
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Author response for "Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo‐controlled trial"
2021
Diabetes, Obesity and Metabolism
Ida K B Rasmussen
Emilie H. Zobel
Rasmus S. Ripa
Bernt Johan von Scholten
Viktor Rotbain Curovic
Jacob Krüger Jensen
Andreas Kjær
Tine W. Hansen
Peter Rossing
Show All
Source
Cite
Save
Citations (0)
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial.
2021
BMJ open diabetes research & care
Emilie H. Zobel
Asger Wretlind
Rasmus S. Ripa
Viktor Rotbain Curovic
Bernt Johan von Scholten
Tommi Suvitaival
Tine W. Hansen
Andreas Kjær
Cristina Legido-Quigley
Peter Rossing
Show All
Source
Cite
Save
Citations (2)
Amiodarone attenuates cardiac Rubidium-82 in consecutive PET/CT scans in a rodent model.
2021
Journal of Nuclear Cardiology
Simon Bentsen
Lia E. Bang
Philip Hasbak
Andreas Kjær
Rasmus S. Ripa
Show All
Source
Cite
Save
Citations (1)
1